BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2642174)

  • 1. C4 and Bf phenotypes in black and Caucasian patients with childhood onset insulin dependent diabetes mellitus.
    Wang C; Rivas ML; Burghen GA; Hudson EC; Wyatt RJ
    J Clin Lab Immunol; 1989 Dec; 30(4):183-90. PubMed ID: 2642174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.
    Hägglöf B; Holmgren G; Holmlund G; Lindblom B; Olaisen B; Teisberg P
    Hum Hered; 1986; 36(4):201-12. PubMed ID: 3639057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles.
    Kelly H; McCann VJ; Kay PH; Dawkins RL
    Immunogenetics; 1985; 22(6):643-51. PubMed ID: 3865895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bf Fl and C22 gene frequencies in patients with insulin dependent diabetes mellitus (IDDM) from three South African populations.
    Orren A; Prescott RA
    Tissue Antigens; 1983 Nov; 22(5):385-8. PubMed ID: 6558983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA, complement C2, C4, properdin factor B and glyoxalase types in South Indian diabetics.
    Kirk RL; Ranford PR; Serjeantson SW; Thompson AR; Munirathnam Chetty SM; John L; Mohan V; Ramachandran A; Snehalatha C; Viswanathan M
    Diabetes Res Clin Pract; 1985 Mar; 1(1):41-7. PubMed ID: 3879724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BF types and the mode of inheritance of insulin-dependent diabetes mellitus (IDDM).
    Raum D; Awdeh Z; Alper CA
    Immunogenetics; 1981; 12(1-2):59-74. PubMed ID: 7009418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bf and C4 phenotypes in patients with psoriasis.
    Wyatt RJ; Wang C; Hudson EC; Jones RM; Noah PW; Rosenberg EW
    Acta Derm Venereol Suppl (Stockh); 1989; 146():211-3. PubMed ID: 2609873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunogenetic markers (BF, C2, C4, 21-OH, TNF alpha, TCR beta, Ig) and insulin-dependent diabetes in the Tunisian population: serological and molecular study].
    Ben Salem M; Ghanem N; Kneissi T; Abbal M; Dugoujon JM; Ben Chibani J; Ellouze F; Lefranc G
    Ann Biol Clin (Paris); 1991; 49(7):389-96. PubMed ID: 1684890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of complement C4 and susceptibility to IDDM and microvascular complications.
    Lhotta K; Auinger M; Kronenberg F; Irsigler K; König P
    Diabetes Care; 1996 Jan; 19(1):53-5. PubMed ID: 8720534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum complement (C3, BF, C4) types in Swedish Saamis.
    Beckman G; Beckman L; Sikström C
    Hum Hered; 1993; 43(6):362-5. PubMed ID: 8288266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of complement alleles C4AQ0 and C4B5 with rheumatoid arthritis in Japanese patients.
    Takeuchi F; Mimori A; Matsuta K; Nakano K; Miyamoto T; Matsuki K; Juji T; Maeda H; Omoto K; Tokunaga K
    Arthritis Rheum; 1989 Jun; 32(6):691-8. PubMed ID: 2567598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human MHC class III (Bf, C2, C4) genes and GLO: their association with other HLA antigens and extended haplotypes in the Spanish population.
    Regueiro JR; Arnaiz-Villena A
    Tissue Antigens; 1988 Jan; 31(1):14-25. PubMed ID: 3341017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement and HLA. Further definition of high-risk haplotypes in insulin-dependent diabetes.
    Rich S; O'Neill G; Dalmasso AP; Nerl C; Barbosa J
    Diabetes; 1985 May; 34(5):504-9. PubMed ID: 3987976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properdin factor B(Bf) allele BfF1 specifies an HLA-B18 diabetogenic haplotype.
    Dornan J; Allan P; Noel EP; Larsen B; Farid NR
    Diabetes; 1980 Jun; 29(6):423-7. PubMed ID: 6929767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C3, BF and C4 polymorphisms in Tunisians.
    Ayed K; Gorgi Y
    Hum Hered; 1990; 40(6):363-7. PubMed ID: 2083950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The susceptibility to insulin-dependent diabetes mellitus is associated with C4 allotypes independently of the association with HLA-DQ alleles in HLA-DR3,4 heterozygotes.
    Thomsen M; Mølvig J; Zerbib A; de Preval C; Abbal M; Dugoujon JM; Ohayon E; Svejgaard A; Cambon-Thomsen A; Nerup J
    Immunogenetics; 1988; 28(5):320-7. PubMed ID: 3139557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human MHC class III genes, Bf and C4. Polymorphism, complotypes and association with MHC class I genes in the Finnish population.
    Partanen J; Koskimies S
    Hum Hered; 1986; 36(5):269-75. PubMed ID: 3639058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properdin factor B polymorphism in Black Americans.
    Budowle B; Go RC; Barger BO; Acton RT
    J Immunogenet; 1981 Dec; 8(6):519-21. PubMed ID: 6916776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement phenotypes in patients with psoriasis.
    Wyatt RJ; Wang C; Hudson EC; Jones RM; Noah PW; Rosenberg EW
    Hum Hered; 1989; 39(6):327-32. PubMed ID: 2613261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.